ScitoVation logo
  • Services
    • Common Problems We Solve
      • Predicting Equivalent Dose in Humans
      • Understanding the Mode of Action of a Compound
      • Screening and Assessing Lead Compounds
    • Technologies
      • In vitro to in vivo extrapolation (IVIVE)
      • PBPK Modeling
      • Toxicogenomic or Pharmacogenomic Studies
    • Organ Specific
      • Liver toxicity
      • Respiratory Toxicity
      • Thyroid toxicity
    • Industries
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
      • Pharma
  • Publications
  • Tools
    • MoAVIZ
    • PLETHEM
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • Scitovation, LLC. PHS-Financial Conflict Of Interest (FCOI) Policy
    • News
  • Request For Quote

Latest News

Featured image for “3D cell culture models & their role in enhancing genotoxicity testing approaches for nano- and advanced-materials”
March 20, 2024

3D cell culture models & their role in enhancing genotoxicity testing approaches for nano- and advanced-materials

Read More
Featured image for “Towards Translating In Vitro Measures Of Thyroid Hormone System Disruption To In Vivo Responses In The Pregnant Rat Via A Biologically Based Dose Response (BBDR) Model”
January 23, 2024

Towards Translating In Vitro Measures Of Thyroid Hormone System Disruption To In Vivo Responses In The Pregnant Rat Via A Biologically Based Dose Response (BBDR) Model

Read More
Featured image for “Towards translating in vitro measures of thyroid hormone system disruption to in vivo responses in the pregnant rat via a biologically based dose response (BBDR) model”
December 14, 2023

Towards translating in vitro measures of thyroid hormone system disruption to in vivo responses in the pregnant rat via a biologically based dose response (BBDR) model

Read More
Featured image for “Animal-free assessment of developmental toxicity: Combining PBPK modeling with the ReproTracker assay”
November 29, 2023

Animal-free assessment of developmental toxicity: Combining PBPK modeling with the ReproTracker assay

Read More
Featured image for “Generic Pharmacokinetic Models for Mother-to-Offspring Transfer of Chemicals”
November 15, 2023

Generic Pharmacokinetic Models for Mother-to-Offspring Transfer of Chemicals

Read More
Featured image for “ToxAIcology – the future of toxicology is AI”
September 13, 2023

ToxAIcology – the future of toxicology is AI

Read More
August 3, 2023

Physiologically based pharmacokinetic modeling as a data analysis and study design tool – case studies in nonlinear pharmacokinetics

Read More
July 11, 2023

ScitoVation Recipient of National Institute of Environmental Health Science Small Business Innovation Research Phase I Award of $269,977

Read More
Featured image for “(R)Evolution in Validation:  Establishing Scientific Confidence in NAMs”
July 5, 2023

(R)Evolution in Validation: Establishing Scientific Confidence in NAMs

Read More
Prev 1 2 3 4 5 … 8 9 Next
Contact Us

6 Davis Drive, Suite 146,
Durham, NC 27709

© 2025 ScitoVation. Privacy Policy
  • Services
    • Common Problems We Solve
      • Predicting Equivalent Dose in Humans
      • Understanding the Mode of Action of a Compound
      • Screening and Assessing Lead Compounds
    • Technologies
      • In vitro to in vivo extrapolation (IVIVE)
      • PBPK Modeling
      • Toxicogenomic or Pharmacogenomic Studies
    • Organ Specific
      • Liver toxicity
      • Respiratory Toxicity
      • Thyroid toxicity
    • Industries
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
      • Pharma
  • Publications
  • Tools
    • MoAVIZ
    • PLETHEM
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • Scitovation, LLC. PHS-Financial Conflict Of Interest (FCOI) Policy
    • News
  • Request For Quote